![conference banner](/images/conference-banner.jpeg)
Abstract
Nef is a viral pathogenicity factor that has an important role in disease progression associated with HIV infection. Yet, no antiviral drugs capable of inhibiting of Nef are available or in clinical trials today. In this review the challenges and potential involved in pharmaceutical targeting of Nef are discussed in light of current understanding of the molecular mechanisms of Nef action, with a special emphasis on effector functions of Nef that are mediated via SH3 domain-directed interactions with host cell proteins.
Keywords: nef, hiv, aids, protein interactions, signal transduction, drug screening
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Title: Therapeutic Targeting of Interactions Between Nef and Host Cell Proteins
Volume: 4 Issue: 4
Author(s): Kalle Saksela
Affiliation:
Keywords: nef, hiv, aids, protein interactions, signal transduction, drug screening
Abstract: Nef is a viral pathogenicity factor that has an important role in disease progression associated with HIV infection. Yet, no antiviral drugs capable of inhibiting of Nef are available or in clinical trials today. In this review the challenges and potential involved in pharmaceutical targeting of Nef are discussed in light of current understanding of the molecular mechanisms of Nef action, with a special emphasis on effector functions of Nef that are mediated via SH3 domain-directed interactions with host cell proteins.
Export Options
About this article
Cite this article as:
Saksela Kalle, Therapeutic Targeting of Interactions Between Nef and Host Cell Proteins, Current Drug Targets - Immune, Endocrine & Metabolic Disorders 2004; 4 (4) . https://dx.doi.org/10.2174/1568005310404040315
DOI https://dx.doi.org/10.2174/1568005310404040315 |
Print ISSN 1568-0088 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5917 |
Related Articles
-
Metabolism and Toxicological Implications of Commonly Used Chemopreventive Drugs Against Breast Cancer/Carcinogenesis
Current Drug Metabolism Targeted Multifunctional Lipid-Based Nanocarriers for Image-Guided Drug Delivery
Anti-Cancer Agents in Medicinal Chemistry A Systematic Review of the Molecular Mechanisms of Uranium -Induced Reproductive Toxicity
Inflammation & Allergy - Drug Targets (Discontinued) The Evolution of Cytochrome P450 Enzymes as Biocatalysts in Drug Discovery and Development
Current Topics in Medicinal Chemistry Interleukin-21 (IL-21) Controls Inflammatory Pathways in the Gut
Endocrine, Metabolic & Immune Disorders - Drug Targets Obesity: Current Treatment and Future Horizons
Mini-Reviews in Medicinal Chemistry Age-Related Decline in Melatonin and Its MT1 Receptor Are Associated with Decreased Sensitivity to Melatonin and Enhanced Mammary Tumor Growth
Current Aging Science Diagnosis of Alterations of Serum Calcium Metabolism
Medicinal Chemistry Molecular and Genetic Mechanisms of Osteoporosis: Implication for Treatment
Current Molecular Medicine Tumor Necrosis Factor-α, a Regulator and Therapeutic Agent on Breast Cancer
Current Pharmaceutical Biotechnology Recent Advances in Positron Emission Tomography (PET) Imaging of Biomolecules: From Chemical Labeling to Cancer Diagnostics
Mini-Reviews in Organic Chemistry Therapeutic Potential of Natural Products in Parkinson’s Disease
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Diabetes Mellitus Type 2 and Functional Foods of Plant Origin
Recent Patents on Biotechnology An Updated Portrait of Pathogenesis, Molecular Markers and Signaling Pathways of Hepatocellular Carcinoma
Current Pharmaceutical Design Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome
Current Pharmaceutical Design Are the Myokines the Mediators of Physical Activity-Induced Health Benefits?
Current Pharmaceutical Design The Clinical Utility of CA 19-9 in Pancreatic Adenocarcinoma: Diagnostic and Prognostic Updates
Current Molecular Medicine Electrotransfer as a Non Viral Method of Gene Delivery
Current Gene Therapy A Role for TGF-β Signaling in Neurodegeneration: Evidence from Genetically Engineered Models
Current Alzheimer Research The Therapeutic Target Hsp90 and Cancer Hallmarks
Current Pharmaceutical Design